logo

For the Inventor, By the Inventor

Kagoshima, Japan

Masanobu Nagano

This inventor holds 11 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1983-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masanobu Nagano. Retrieved from https://idiyas.com/inventor/masanobu-nagano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 100.0

Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 105(Granted Patents)


Location History:

  • Ikeda, JP (1983 - 1985)
  • Suita, JP (1986)
  • Kawanishi, JP (1989 - 1995)
  • Kagoshima, JP (1998 - 2000)

Company Filing History:

goldMedal11 out of 940 
 
Fujisawa Pharmaceutical Company, Ltd.
 patents

Years Active: 1983-2000

Loading Chart...
11 patents (USPTO):Explore Patents
1. 6025375 - 4,5-diaryloxazole derivatives (2000-02-15),
2. 5863918 - Naphthalene derivatives (1999-01-26),
3. 5763489 - Naphthalene derivatives as prostaglandin I.sub.2 agonsists (1998-06-09),
4. 5387710 - Ethanolamine derivatives having sympathomimetic and anti-pollakiuria (1995-02-07),
5. 4920129 - Anti-ulcerative imidazopyridine compounds (1990-04-24),
6. 4831041 - Imidazopyridine compounds and processes for preparation thereof (1989-05-16),
7. 4564621 - .alpha.-Aryl-.alpha.-pyridylalkanoic acid derivatives, process for (1986-01-14),
8. 4563455 - Antiulcer fused imidazole compounds (1986-01-07),
9. 4543356 - Quinazoline derivatives (1985-09-24),
10. 4429126 - Sodium salt of (1984-01-31),
11. 4377580 - Tricyclic quinazoline derivatives (1983-03-22),

Title: The Innovative Contributions of Masanobu Nagano

Introduction

Masanobu Nagano is a prominent inventor based in Kagoshima, Japan. He has made significant contributions to the field of heterocyclic compounds, holding a total of 11 patents. His work has had a considerable impact on pharmaceutical research and development.

Latest Patents

Among his latest patents are the 4,5-diaryloxazole derivatives, which are heterocyclic compounds characterized by specific structural formulas. Another notable patent involves naphthalene derivatives, which also feature unique structural characteristics. These innovations demonstrate his expertise in developing complex chemical compounds.

Career Highlights

Masanobu Nagano is currently associated with Fujisawa Pharmaceutical Company, Ltd., where he continues to advance his research. His work at this esteemed company has allowed him to explore various aspects of pharmaceutical chemistry, contributing to the development of new therapeutic agents.

Collaborations

Throughout his career, Nagano has collaborated with notable colleagues, including Ikuo Ueda and Masayuki Kato. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Masanobu Nagano's contributions to the field of chemistry and pharmaceuticals are noteworthy. His innovative patents and collaborations reflect his dedication to advancing scientific knowledge and improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…